NASDAQ: OCXOncocyte Corp Stock Ownership - Who owns Oncocyte?
Insider buying vs selling
Have Oncocyte Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrea S. James | Chief Financial Officer | 2025-02-07 | 97,561 | $2.05 | $200.00kBuy |
| Patrick W. Smith | 10% Owner | 2025-02-07 | 385,814 | $2.05 | $790.92kBuy |
| Patrick W. Smith | 10% Owner | 2025-02-07 | 1,077,600 | $2.05 | $2.21MBuy |
| Broadwood Partners LP | 10% Owner | 2025-02-06 | 660,207 | $2.05 | $1.35MBuy |
| Broadwood Partners LP | 10% Owner | 2025-02-06 | 4,505,488 | $2.05 | $9.24MBuy |
| Patrick W. Smith | 10% Owner | 2025-02-04 | 25 | $2.02 | $50.50Buy |
| Patrick W. Smith | 10% Owner | 2025-01-31 | 890 | $2.01 | $1.79kBuy |
| Patrick W. Smith | 10% Owner | 2025-01-30 | 318 | $2.01 | $639.18Buy |
| Patrick W. Smith | 10% Owner | 2025-01-29 | 3,880 | $2.01 | $7.80kBuy |
| Patrick W. Smith | 10% Owner | 2025-01-14 | 100 | $2.08 | $208.00Buy |
OCX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OCX insiders and whales buy or sell their stock.
OCX Shareholders
What type of owners hold Oncocyte Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pura Vida Investments LLC | 122.11% | 34,922,779 | $92.55M | Insider |
| Broadwood Partners LP | 91.35% | 26,126,461 | $69.24M | Insider |
| Broadwood Capital Inc | 39.90% | 11,410,100 | $30.24M | Institution |
| Lineage Cell Therapeutics Inc | 21.12% | 6,041,154 | $16.01M | Insider |
| John Peter Gutfreund | 17.13% | 4,900,047 | $12.99M | Insider |
| George Karfunkel | 12.80% | 3,659,860 | $9.70M | Insider |
| Patrick W. Smith | 11.39% | 3,258,485 | $8.63M | Insider |
| Awm Investment Company Inc | 9.87% | 2,822,530 | $7.48M | Institution |
| Pura Vida Investments LLC | 3.31% | 947,134 | $2.51M | Institution |
| Alfred D. Kingsley | 2.10% | 601,990 | $1.60M | Insider |
OCX vs Diagnostic & Research Stocks
Oncocyte Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.